BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 146 found
  Current Search:  vancomycin: 226, hydrochloride: 146     

HTML
52%
Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S
MORRISTOWN, N.J., Dec.

1 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S.

Food & Drug Administration to market Bupropion ...

Pharmacy Choice:  Dec 2 2008 2:20AM
Matching: hydrochloride
Find similar documents
HTML
52%
Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
Watson Pharmaceuticals, Inc.

has announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the FDA on its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release...

PharmaceuticalProcessing:  Dec 2 2008 1:03PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan confirms first-to-file patent challenge of AMRIX capsules
Medical Patent News Mylan Inc.

has confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc.

and Anesta AG in connection with the filing of an Abbreviated New Drug Application...

News-Medical.Net:  Dec 2 2008 10:37AM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
PITTSBURGH, Dec.

1 /PRNewswire-FirstCall/ -- Mylan Inc.

(NYSE: MYL) today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc.

and Anesta AG in connection with the...

Pharmacy Choice:  Dec 2 2008 2:21AM
Matching: hydrochloride
Find similar documents
HTML
52%
Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL 150 mg
/PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.

, a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the United States Food and Drug...

Pharma Live:  Dec 1 2008 7:43PM
Matching: hydrochloride
Find similar documents
HTML
52%
Actavis Receives Approval of Generic Wellbutrin XL 150mg in the U.S
/PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S.

Food & Drug Administration to market Bupropion Hydrochloride extended-release...

Pharma Live:  Dec 1 2008 7:43PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
- Mylan believes it has 180 days of sole marketing exclusivity - PITTSBURGH, Dec.

1 /PRNewswire-FirstCall/ -- Mylan Inc.

(NYSE: MYL) today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by...

PR Newswire:  Dec 1 2008 3:13PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX
- Mylan believes it has 180 days of sole marketing exclusivity - PITTSBURGH, December 01, 2008 /PRNewswire-FirstCall/ -- Mylan Inc.

today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon...

Pharma Live:  Dec 1 2008 2:10PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
PITTSBURGH, Dec.

1 /PRwire-FirstCall/ -- Mylan Inc.

(NYSE: MYL) today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc.

and Anesta AG in connection with the filing...

San Antonio Business Journal:  Dec 1 2008 1:30PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
PITTSBURGH, Dec.

1 /PRNewswire-FirstCall/ -- Mylan Inc.

(NYSE: MYL) today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc.

and Anesta AG in connection with the...

San Francisco Business Times:  Dec 1 2008 1:28PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
PITTSBURGH, Dec.

1 /PRwire-FirstCall/ -- Mylan Inc.

(NYSE: MYL) today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc.

and Anesta AG in connection with the filing...

Cincinnati Business Journal:  Dec 1 2008 1:28PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
PITTSBURGH, Dec.

1 /PRNewswire-FirstCall/ -- Mylan Inc.

(NYSE: MYL) today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc.

and Anesta AG in connection with the...

Atlanta Business Chronicle:  Dec 1 2008 1:27PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
PITTSBURGH, Dec.

1 /PRNewswire-FirstCall/ -- Mylan Inc.

(NYSE: MYL) today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc.

and Anesta AG in connection with the...

Nashville Business Journal:  Dec 1 2008 1:27PM
Matching: hydrochloride
Find similar documents
HTML
52%
Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
Mylan Inc.

(NYSE: MYL) today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc.

and Anesta AG in connection with the filing of an Abbreviated New Drug Application (ANDA...

The Business Journal Phoenix:  Dec 1 2008 1:18PM
Matching: hydrochloride
Find similar documents
HTML
52%
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
FRAZER, Pa.

and PHILADELPHIA, Nov.

26 /PRNewswire-FirstCall/ -- Cephalon, Inc.

(Nasdaq: CEPH) and Eurand, Inc.

(Nasdaq: EURX) today announced that they have filed a lawsuit in U.S.

District Court in Delaware against Mylan...

Rehab Manegement:  Dec 1 2008 9:39AM
Matching: hydrochloride
Find similar documents
HTML
52%
ScinoPharm gets US patent for novel crystal forms of Irinotecan Hydrochloride
ScinoPharm, an active pharmaceutical ingredient (API) specialist, has been granted US Patent No.

7,435,818 entitled 'Novel Crystal Forms of Irinotecan Hydrochloride.' The new patent provides for novel crystalline forms of irinotecan...

PharmaBiz:  Nov 29 2008 10:04AM
Matching: hydrochloride
Find similar documents
HTML
52%
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
FRAZER, Pa.

and PHILADELPHIA, Nov.

26 /PRNewswire-FirstCall/ -- Cephalon, Inc.

and Eurand, Inc.

today announced that they have filed a lawsuit in U.S.

District Court in Delaware against Mylan Pharmaceuticals, Inc.

and its...

KRON4:  Nov 29 2008 12:50AM
Matching: hydrochloride
Find similar documents
HTML
52%
Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
CORONA, Calif., Nov.

26 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.

(NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received final approval today...

Pharmacy Choice:  Nov 28 2008 4:12PM
Matching: hydrochloride
Find similar documents
HTML
52%
Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
Watson Pharmaceuticals, Inc.

, a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the United States Food and Drug Administration on its...

PR-USA.net:  Nov 28 2008 2:57AM
Matching: hydrochloride
Find similar documents
HTML
52%
Watson Pharmaceuticals Wins Final FDA Nod For Generic Wellbutrin XL
(financialwire.net via COMTEX) -- WPI | Quote | Chart | News | PowerRating -- November 28, 2008 (FinancialWire) -- Watson Pharmaceuticals, Inc.'s (NYSE: WPI | Quote | Chart | News | PowerRating) (Current Market Cap: US$2.46 Bil.) Watson...
TradingMarkets:  Nov 28 2008 2:01PM
Matching: hydrochloride
Find similar documents
HTML
52%
Watson Pharmaceuticals receives FDA approval for Wellbutrin XL
Watson Pharmaceuticals, a leading specialty pharmaceutical company, announced that its subsidiary, Watson Laboratories has received final approval today from the Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for...
Bio Spectrum Asia:  Nov 28 2008 10:35AM
Matching: hydrochloride
Find similar documents
HTML
52%
Cephalon, Eurand file patent infringement lawsuit against Mylan and Barr
Cephalon, Inc.

and Eurand, Inc.

announced that they have filed a lawsuit in US District Court in Delaware against Mylan Pharmaceuticals, Inc.

and its subsidiary, Mylan, Inc., and Barr Pharmaceuticals, Inc.

and its subsidiary, Barr...

PharmaBiz:  Nov 28 2008 6:21AM
Matching: hydrochloride
Find similar documents
HTML
52%
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
FRAZER, Pa.

and PHILADELPHIA, Nov.

26 /PRNewswire-FirstCall/ -- Cephalon, Inc.

and Eurand, Inc.

today announced that they have filed a lawsuit in U.S.

District Court in Delaware against Mylan Pharmaceuticals, Inc.

and its...

Financials.com:  Nov 28 2008 2:14AM
Matching: hydrochloride
Find similar documents
HTML
52%
Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
CORONA, Calif., Nov.

26 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.

, a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the...

KRON4:  Nov 27 2008 9:47AM
Matching: hydrochloride
Find similar documents
HTML
52%
Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
CORONA, Calif., Nov.

26 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.

, a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the...

Kait 8:  Nov 27 2008 5:16AM
Matching: hydrochloride
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.